Brief: Unicycive Announces First Quarter Financial Results And Provides Business Update

Unicycive Therapeutics

12/05/2022 12:08

May 12 (Reuters) - Unicycive Therapeutics Inc  UNCY.O :
    * UNICYCIVE ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND
PROVIDES
BUSINESS UPDATE
    * UNICYCIVE THERAPEUTICS INC- ON TRACK TO INITIATE CLINICAL
BIOEQUIVALENCE STUDY OF RENAZORB TO TREAT HYPERPHOSPHATEMIA IN
HEALTHY VOLUNTEERS IN Q2 2022
    * UNICYCIVE THERAPEUTICS INC- PLANS TO INITIATE PHASE 1
STUDY FOR
UNI-494 IN SECOND HALF OF 2022
    * UNICYCIVE THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.24
    * UNICYCIVE THERAPEUTICS - AS OF MAR 31, CASH, CASH
EQUIVALENTS
TOTALED $13.6 MILLION, BELIEVES IS SUFFICIENT TO SUPPORT IT
THROUGH TO SEVERAL MILESTONES

Source text for Eikon:  ID:nGNXN5xk4 
Further company coverage:  UNCY.O 

 ((Reuters.Briefs@thomsonreuters.com;))